Diabetic Nephropathies Clinical Trials

12 recruiting

Diabetic Nephropathies Trials at a Glance

13 actively recruiting trials for diabetic nephropathies are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Los Angeles, Portland, and Aurora. Lead sponsors running diabetic nephropathies studies include University of Pennsylvania, Alessandro Doria, and Ain Shams University.

Browse diabetic nephropathies trials by phase

Treatments under study

About Diabetic Nephropathies Clinical Trials

Looking for clinical trials for Diabetic Nephropathies? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetic Nephropathies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetic Nephropathies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences96 enrolled50 locationsNCT06466135
Recruiting
Phase 3

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Diabetic NephropathiesKidney Failure, Chronic
Alessandro Doria150 enrolled19 locationsNCT06217302
Recruiting

Transformative Research in Diabetic Nephropathy

Diabetic NephropathiesDiabetic Glomerulosclerosis
University of Pennsylvania400 enrolled17 locationsNCT02986984
Recruiting

Transformative Research in Diabetic Nephropathy 2.0

Diabetes Mellitus, Type 2Kidney DiseasesDiabetic Nephropathies+1 more
University of Pennsylvania200 enrolled1 locationNCT07444203
Recruiting
Phase 2

Formoterol in Diabetes

Diabetic Kidney DiseaseDiabetic Nephropathies
Medical University of South Carolina120 enrolled1 locationNCT07022418
Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Chronic Kidney DiseasesMolecular Sequence VariationAlbuminuria+4 more
Herlev Hospital300 enrolled13 locationsNCT04916132
Recruiting
Not Applicable

Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus MeSH:D003924Periodontitis MeSH:D010518Diabetic Nephropathies MeSH:D003928
Dow University of Health Sciences46 enrolled1 locationNCT07256613
Recruiting
Phase 4

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Chronic Kidney DiseaseDiabetic NephropathiesChronic Kidney Disease (Stages 4 and 5)+5 more
Ace Cells Lab Limited300 enrolled1 locationNCT07187713
Recruiting
Not Applicable

Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease

Healthy VolunteerDiabetesHypoxia+2 more
Poitiers University Hospital30 enrolled1 locationNCT06846034
Recruiting
Not Applicable

Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy

Diabetes Mellitus, Type 2Diabetic Nephropathies
Riphah International University60 enrolled1 locationNCT06778018
Recruiting
Phase 2Phase 3

Clinical Outcome of Vinpocetine in Diabetic Nephropathy

Diabetic Kidney DiseaseDiabetic Nephropathies
Ain Shams University64 enrolled2 locationsNCT06441591
Recruiting
Phase 4

Efficacy and Safety of Telmisartan Compared With Losartan

HypertensionDiabetic Nephropathies
Chong Kun Dang Pharmaceutical98 enrolled1 locationNCT06431477
Recruiting

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

Type 1 DiabetesDiabetic Kidney DiseaseDiabetic Nephropathies+2 more
University of Colorado, Denver100 enrolled1 locationNCT05319990